Cortical Hyperperfusion on MRI Arterial Spin-Labeling during the Interictal Period of Patients with Migraine Headache

References

1. 1.↵
   1. Park S,
   2. Lee DA,
   3. Lee HJ, et al

   . Brain networks in migraine with and without aura: an exploratory arterial spin labeling MRI study. Acta Neurol Scand 2022;145:208–14 doi:10.1111/ane.13536 pmid:34633068

   CrossRefPubMed
2. 2.↵
   1. Russo A,
   2. Silvestro M,
   3. Tessitore A, et al

   . Arterial spin labeling MRI applied to migraine: current insights and future perspectives. J Headache Pain 2023;24:71 doi:10.1186/s10194-023-01597-y pmid:37322466

   CrossRefPubMed
3. 3.↵
   1. Saçmacı H,
   2. Tanik N,
   3. İnan LE

   . Current perspectives on the impact of chronic migraine on sleep quality: a literature review. Nat Sci Sleep 2022;14:1783–800 doi:10.2147/NSS.S335949 pmid:36225323

   CrossRefPubMed
4. 4.↵
   1. Liu M,
   2. He E,
   3. Fu X, et al

   . Cerebral blood flow self-regulation in depression. J Affect Disord 2022;302:324–31 doi:10.1016/j.jad.2022.01.057 pmid:35032508

   CrossRefPubMed
5. 5.↵
   1. Park S,
   2. Hong H,
   3. Kim RY, et al

   . Firefighters have cerebral blood flow reductions in the orbitofrontal and insular cortices that are associated with poor sleep quality. Nat Sci Sleep 2021;13:1507–17 doi:10.2147/NSS.S312671 pmid:34531693

   CrossRefPubMed
6. 6.↵
   1. Müller M,
   2. Marziniak M

   . The linear behavior of the system middle cerebral artery flow velocity and blood pressure in patients with migraine: lack of autonomic control? Stroke 2005;36:1886–90 doi:10.1161/01.STR.0000177886.94134.92 pmid:16100026

   Abstract/FREE Full Text
7. 7.↵
   1. Iyengar S,
   2. Johnson KW,
   3. Ossipov MH, et al

   . CGRP and the trigeminal system in migraine. Headache 2019;59:659–81 doi:10.1111/head.13529 pmid:30982963

   CrossRefPubMed
8. 8.↵
   1. Nisar A,
   2. Ahmed Z,
   3. Yuan H

   . Novel therapeutic targets for migraine. Biomedicines 2023;11:569 doi:10.3390/biomedicines11020569 pmid:36831105

   CrossRefPubMed
9. 9.↵
   1. Hong KW,
   2. Pyo KM,
   3. Lee WS, et al

   . Pharmacological evidence that calcitonin gene-related peptide is implicated in cerebral autoregulation. Am J Physiol 1994;266:H11–16 doi:10.1152/ajpheart.1994.266.1.H11 pmid:7508205

   CrossRefPubMed
10. 10.↵
    1. Kamm K

    . CGRP and migraine: what have we learned from measuring CGRP in patient with migraine so far? Front Neurol 2022;13:930383 doi:10.3389/fneur.2022.930383 pmid:35968305

    CrossRefPubMed
11. 11.↵
    1. Alpuente A,
    2. Gallardo VJ,
    3. Asskour L, et al

    . Salivary CGRP and erenumab treatment response: towards precision medicine in migraine. Ann Neurol 2022;92:846–59 doi:10.1002/ana.26472 pmid:36054144

    CrossRefPubMed
12. 12.↵
    1. Biscetti L,
    2. Cresta E,
    3. Cupini LM, et al

    . The putative role of neuroinflammation in the complex pathophysiology of migraine: from bench to bedside. Neurobiol Dis 2023;180:106072 doi:10.1016/j.nbd.2023.106072 pmid:36907522

    CrossRefPubMed
13. 13.↵
    1. Ohtomo S,
    2. Otsubo H,
    3. Arai H, et al

    . Hyperperfusion in the thalamus on arterial spin labelling indicates non-convulsive status epilepticus. Brain Commun 2021;3:fcaa223 doi:10.1093/braincomms/fcaa223 pmid:33501426

    CrossRefPubMed
14. 14.↵
    1. Hauf M,
    2. Slotboom J,
    3. Nirkko A, et al

    . Cortical regional hyperperfusion in nonconvulsive status epilepticus measured by dynamic brain perfusion CT. AJNR Am J Neuroradiol 2009;30:693–98 doi:10.3174/ajnr.A1456 pmid:19213823

    Abstract/FREE Full Text
15. 15.↵
    1. Pourshoghi A,
    2. Danesh A,
    3. Tabby DS, et al

    . Cerebral reactivity in patient with migraine measured with functional near-infrared spectroscopy. Eur J Med Res 2015;20:96 doi:10.1186/s40001-015-0190-9 pmid:26644117

    CrossRefPubMed
16. 16.↵
    1. Fu T,
    2. Liu L,
    3. Huang X, et al

    . Cerebral blood flow alterations in patient with migraine with and without aura: an arterial spin labeling study. J Headache Pain 2022;23:131 doi:10.1186/s10194-022-01501-0 pmid:36195842

    CrossRefPubMed
17. 17.↵
    1. Szabo E,
    2. Ashina S,
    3. Melo-Carrillo A, et al

    . Peripherally acting anti-CGRP monoclonal antibodies alter cortical gray matter thickness in patient with migraine: a prospective cohort study. Neuroimage Clin 2023;40:103531 doi:10.1016/j.nicl.2023.103531 pmid:37866119

    CrossRefPubMed
18. 18.↵
    Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211 doi:10.1177/0333102417738202 pmid:29368949

    CrossRefPubMed
19. 19.↵
    1. Alsop DC,
    2. Detre JA,
    3. Golay X, et al

    . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European Consortium for ASL in Dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

    CrossRefPubMed
20. 20.↵
    1. Iwanaga T,
    2. Harada M,
    3. Kubo H, et al

    . Operator-bias-free comparison of quantitative perfusion maps acquired with pulsed-continuous arterial spin labeling and single-photon-emission computed tomography. Magn Reson Med Sci 2014;13:239–49 doi:10.2463/mrms.2013-0117 pmid:25167874

    CrossRefPubMed
21. 21.↵
    1. Inoue Y,
    2. Tanaka Y,
    3. Hata H, et al

    . Arterial spin-labeling evaluation of cerebrovascular reactivity to acetazolamide in healthy subjects. AJNR Am J Neuroradiol 2014;35:1111–16 doi:10.3174/ajnr.A3815 pmid:24371025

    Abstract/FREE Full Text
22. 22.↵
    1. Shin HE,
    2. Park JW,
    3. Kim YI, et al

    . Headache Impact Test-6 (HIT-6) scores for patient with migraine: their relation to disability as measured from a headache diary. J Clin Neurol 2008;4:158–63 doi:10.3988/jcn.2008.4.4.158 pmid:19513291

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Soldatos CR,
    2. Dikeos DG,
    3. Paparrigopoulos TJ

    . Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res 2000;48:555–60 doi:10.1016/s0022-3999(00)00095-7 pmid:11033374

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Arnarson TO,
    2. Olason DT,
    3. Smári J, et al

    . The Beck Depression Inventory Second Edition (BDI-II): psychometric properties in Icelandic student and patient populations. Nord J Psychiatry 2008;62:360–65 doi:10.1080/08039480801962681 pmid:18752106

    CrossRefPubMedWeb of Science
25. 25.↵
    1. McCulloch J,
    2. Uddman R,
    3. Kingman TA, et al

    . Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A 1986;83:5731–35 doi:10.1073/pnas.83.15.5731 pmid:3488550

    Abstract/FREE Full Text
26. 26.↵
    1. Mulder IA,
    2. Li M,
    3. de Vries T, et al

    . Anti-migraine calcitonin gene-related peptide receptor antagonists worsen cerebral ischemic outcome in mice. Ann Neurol 2020;88:771–84 doi:10.1002/ana.25831 pmid:32583883

    CrossRefPubMed
27. 27.↵
    1. Roth T,
    2. Roehrs T,
    3. Pies R

    . Insomnia: pathophysiology and implications for treatment. Sleep Med Rev 2007;11:71–79 doi:10.1016/j.smrv.2006.06.002 pmid:17175184

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Smith MT,
    2. Perlis ML,
    3. Chengazi VU, et al

    . Neuroimaging of NREM sleep in primary insomnia: a Tc-99-HMPAO single photon emission computed tomography study. Sleep 2002;25:325–35

    PubMedWeb of Science
29. 29.↵
    1. Karakuła H,
    2. Opolska A,
    3. Kowal A, et al

    . Does diet affect our mood? The significance of folic acid and homocysteine [in Polish]. Pol Merkur Lekarski 2009;26:136–41 pmid:19388520

    PubMed
30. 30.↵
    1. Lai WK,
    2. Kan MY

    . Homocysteine-induced endothelial dysfunction. Ann Nutr Metab 2015;67:1–12 doi:10.1159/000437098 pmid:26201664

    CrossRefPubMed